Studies
Post-Liver Transplant Recurrent Human Hepatocellular Carcinoma Study (RHCCS)
Post-Liver Transplant Recurrent Human Hepatocellular Carcinoma Study (RHCCS)
Request Access
Overview
Selected Publications (1)
HERC5 is a prognostic biomarker for post-liver transplant recurrent human hepatocellular carcinoma
F. Xue, B. Higgs, Jiaqi Huang, et al.. (2015). Journal of Translational Medicine. Cited 28 times.
https://doi.org/10.1186/s12967-015-0743-2
